STOCK TITAN

NMTC (NMTC) director gains new stock options and 41,929 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

NEUROONE MEDICAL TECHNOLOGIES Corp director Jeffrey S. Mathiesen received new equity compensation. On April 3, 2026, he was granted options to purchase 26,036 shares of common stock at an exercise price of $0.795 per share, expiring on April 2, 2036. These options vest in 12 equal monthly installments over one year.

On the same date, he also received 41,929 restricted stock units, which vest in 12 equal monthly installments over one year at the end of each month. Following these grants, he directly owns 156,343 shares of common stock. Both grants are compensation awards rather than open-market purchases.

Positive

  • None.

Negative

  • None.
Insider MATHIESEN JEFFREY S
Role Director
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock 26,036 $0.00 --
Grant/Award Common Stock 41,929 $0.00 --
Holdings After Transaction: Option to Purchase Common Stock — 26,036 shares (Direct); Common Stock — 156,343 shares (Direct)
Footnotes (1)
  1. Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
Option grant size 26,036 options Granted April 3, 2026 to purchase common stock
Option exercise price $0.795 per share Strike price for 26,036 options
RSU grant size 41,929 RSUs Restricted stock units granted April 3, 2026
Common shares after grant 156,343 shares Direct common stock holdings following RSU grant
Option expiration April 2, 2036 Expiration date of 26,036-share option
Vesting schedule 12 monthly installments Applies to both options and RSUs over one year
restricted stock units financial
"Represents a grant of restricted stock units, which vest in 12 equal monthly installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting financial
"vest in 12 equal monthly installments over a one-year period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "0.7950""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-04-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MATHIESEN JEFFREY S

(Last)(First)(Middle)
C/O NEUROONE MEDICAL TECHNOLOGIES CORP
7599 ANAGRAM DRIVE

(Street)
EDEN PRAIRIE MINNESOTA 55344

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NEUROONE MEDICAL TECHNOLOGIES Corp [ NMTC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/03/2026A41,929(1)A$0156,343D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$0.79504/03/2026A26,036 (2)04/02/2036Common Stock26,036$026,036D
Explanation of Responses:
1. Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
2. The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
/s/ Emily Johns, by Power of Attorney04/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did NMTC director Jeffrey Mathiesen receive in this Form 4?

Jeffrey Mathiesen received two equity awards: 26,036 stock options with a $0.795 exercise price and 41,929 restricted stock units. Both awards are compensation grants, not open-market transactions, and vest in monthly installments over one year.

How do the new restricted stock units for NMTC vest for Jeffrey Mathiesen?

The 41,929 restricted stock units vest in 12 equal monthly installments over one year. Vesting occurs at the end of each month, meaning Mathiesen gradually receives the underlying shares throughout the year as service-based compensation.

What are the key terms of Jeffrey Mathiesen’s NMTC stock options?

Mathiesen’s option covers 26,036 shares of NMTC common stock at an exercise price of $0.795 per share. The option vests in 12 equal monthly installments over one year and carries an expiration date of April 2, 2036.

Are the NMTC transactions in this Form 4 open-market buys or compensation grants?

The transactions are compensation grants, not open-market buys. Both the stock options and restricted stock units are coded as acquisitions from grants, with a reported price of $0.00 per share, reflecting awards rather than purchases.

How many NMTC common shares does Jeffrey Mathiesen hold after these grants?

After the reported transactions, Mathiesen directly holds 156,343 shares of NMTC common stock. This figure reflects his position following the grant of 41,929 restricted stock units, which will convert into shares as they vest over the one-year schedule.

What is the significance of the vesting schedule for NMTC’s director equity awards?

Both the options and restricted stock units vest in 12 equal monthly installments over one year. This structure ties compensation to ongoing board service, gradually delivering value and aligning the director’s incentives with the company’s performance over the vesting period.